Movement Disorders (revue) - Exploration (Accueil)

Index « Keywords » - entrée « Administration, Oral »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Administration, Intravaginal < Administration, Oral < Administration, Sublingual  Facettes :

List of bibliographic references indexed by Administration, Oral

Number of relevant bibliographic references: 39.
[20-40] [0 - 20][0 - 39]
Ident.Authors (with country if any)Title
004F34 (1998) Elaine J. Skalabrin [États-Unis] ; Edward R. Laws Jr. [États-Unis] ; James P. Bennett Jr. [États-Unis]Pallidotomy improves motor responses and widens the levodopa therapeutic window in Parkinson's disease
004F55 (1998) Ohara [Japon] ; Ryoichi Hayashi [Japon] ; Hiroki Momoi [Japon] ; Jun Miki [Japon] ; Nobuo Yanagisawa [Japon]Mexiletine in the treatment of spasmodic torticollis
005093 (1998) Robert A. Hauser [États-Unis] ; Eric Molho [États-Unis] ; Heidi Shale [États-Unis] ; Simon Pedder [États-Unis] ; Ernest E. Dorflinger [États-Unis]A pilot evaluation of the tolerability, safety, and efficacy of tolcapone alone and in combination with oral selegiline in untreated Parkinson's disease patients
005564 (1996) Burton L. Scott [États-Unis] ; Randolph W. Evans [États-Unis] ; Joseph Jankovic [États-Unis]Treatment of palatal myoclonus with sumatriptan
005596 (1996) Pahwa [États-Unis] ; J. Marjama [États-Unis] ; D. Mcguire [États-Unis] ; K. Lyons [États-Unis] ; F. Zwiebel [États-Unis] ; P. Silverstein [États-Unis] ; R. Ward [États-Unis] ; W. C. Koller [États-Unis]Pharmacokinetic comparison of sinemet and atamet (Generic carbidopa/levodopa): A single‐dose study
005675 (1996) Ikeda [Japon] ; Hiroshi Shibasaki [Japon] ; Kunio Tasgiro [Japon] ; Yoshikuni Mizuno [Japon] ; Jun Kimura [Japon]Clinical trial of piracetam in patients with myoclonus: Nationwide multiinstitution study in Japan
005710 (1996) Lance Smith [Royaume-Uni] ; Maria De Salvia [Royaume-Uni] ; Jenner [Royaume-Uni] ; C. David Marsden [Royaume-Uni]An appraisal of the antiparkinsonian activity of piribedil in 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine‐treated common marmosets
005887 (1995) Lagueny [France] ; P. Burbaud [France] ; G. Le Masson [France] ; F. X. Bergouignan [France] ; X. Ferrer [France] ; J. Julien [France]Involvement of respiratory muscles in adult‐onset dystonia: A clinical and electrophysiological study
005921 (1995) R. K. B. Pearce ; M. Jackson ; L. Smith ; Jenner ; C. D. Marsden [Royaume-Uni]Chronic L‐DOPA administration induces dyskinesias in the 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine‐treated common marmoset (Callithrix jacchus)
005B72 (1994) L. Verhagen Metman [États-Unis] ; J. Hoff [États-Unis] ; M. M. Mouradian [États-Unis] ; Chase [États-Unis]Fluctuations in plasma levodopa and motor responses with liquid and tablet levodopa/carbidopa
005C02 (1994) S. Rose [Royaume-Uni] ; Jenner [Royaume-Uni] ; C. D. Marsden [Royaume-Uni]Chronic administration does not alter the accumulation of L‐dopa into muscle
005D11 (1993) Mark Forrest Gordon [États-Unis] ; Rolando Diaz-Olivo [États-Unis] ; Ann L. Hunt [États-Unis] ; Fahn [États-Unis]Therapeutic trial of milacemide in patients with myoclonus and other intractable movement disorders
006139 (1991) Kurlan [États-Unis] ; Michael H. Kim [États-Unis] ; Don M. Gash [États-Unis]Oral levodopa dose‐response study in MPTP‐induced hemiparkinsonian monkeys: Assessment with a new rating scale for monkey parkinsonism
006201 (1991) Gancher [États-Unis] ; John G. Nutt [États-Unis] ; William R. Woodward [États-Unis]Absorption of apomorphine by various routes in parkinsonism
006329 (1990) J. Vaamonde [Espagne] ; M. R. Luquin [Espagne] ; Obeso [Espagne]Dopaminergic responsiveness to apomorphine after chronic treatment with subcutaneous lisuride infusion in Parkinson's disease
006341 (1990) Poewe [Autriche] ; G. Luef [Autriche] ; B. Kleedorfer [Autriche] ; M. Emre [Suisse]Antiparkinsonian activity of a non‐ergot dopamine agonist, CV 205‐502, in patients with fluctuating Parkinson's disease
006611 (1987) J. L. Montastruc [France] ; Celsis [France] ; A. Agniel [France] ; J. F. Demonet [France] ; B. Doyon [France] ; M. Puel [France] ; J. P. Marc-Vergnes [France] ; A. Rascol [France]Levodopa‐induced regional cerebral blood flow changes in normal volunteers and patients with Parkinson's disease
006630 (1987) F. Grandas ; N. Quinn ; P. Critchley ; A. Rohan ; Marsden ; S. M. StahlAntiparkinsonian activity of single oral dose of PHNO
006631 (1987) M. Nomoto [Royaume-Uni] ; S. Stahl [Royaume-Uni] ; P. Jenner [Royaume-Uni] ; Marsden [Royaume-Uni]Antiparkinsonian activity of (+)‐PHNO in the MPTP‐treated common marmoset

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Main/Exploration
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdEn.i -k "Administration, Oral" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdEn.i  \
                -Sk "Administration, Oral" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    KwdEn.i
   |clé=    Administration, Oral
}}

Wicri

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024